No Dominant Sponsors In US FDA's 2016 Novel Approvals Class
No company received more than two approvals among the 28 novel agents approved in 2016 by US FDA's drug and biologics centers combined.
No company received more than two approvals among the 28 novel agents approved in 2016 by US FDA's drug and biologics centers combined.